Andreas N. Neophytides, MD

Clinical Professor, Department of Neurology

Positions

Clinical Professor, Department of Neurology at NYU Grossman School of Medicine

Assistant Director, EMG

Graduate Education

MD from University of Athens

Residency And Fellowship Training

Residency, Medical School of the University of Athens, Greece

Phone

212-263-7744

Is this your profile?
Edit profile
Academic office

222 East 41st Street

New York, NY 10017

Progressive ataxia and palatal tremor

Hainline, Clotilde; Neophytides, Andreas; Borja, Maria J; Galetta, Steven L

Neurology. Clinical practice. 2017 Aug; 7(4):e37-e38

Dopamine agonists in Parkinson's Disease

Lieberman, A; Gopinathan, G; Neophytides, A; Goldstein, M

Parkinson's disease. Chapman and Hall Medical, 1990. p.509-535. (591772)

Randomized double-blind cross-over study of Sinemet-controlled release (CR4 50/200) versus Sinemet 25/100 in Parkinson's disease

Lieberman, A; Gopinathan, G; Miller, E; Neophytides, A; Baumann, G; Chin, L

European neurology. 1990 Dec; 30(2):75-8

Deprenyl in the treatment of symptom fluctuations in advanced Parkinson's disease

Golbe LI; Lieberman AN; Muenter MD; Ahlskog JE; Gopinathan G; Neophytides AN; Foo SH; Duvoisin RC

Clinical neuropharmacology. 1988 Feb; 11(1):45-55

Deprenyl versus placebo in Parkinson disease: a double-blind study

Lieberman, A N; Gopinathan, G; Neophytides, A; Foo, S H

New York state journal of medicine. 1987 Dec; 87(12):646-9

D-1 and D-2 agonists in Parkinson's disease

Lieberman AN; Goldstein M; Gopinathan G; Neophytides A

Canadian journal of neurological sciences. 1987 Aug; 14(3 Suppl):466-73

Advanced Parkinson's disease: use of partial dopamine agonist, ciladopa

Lieberman, A; Gopinathan, G; Neophytides, A; Pasternack, P; Goldstein, M

Neurology. 1987 May; 37(5):863-5

Deprenyl in Parkinson's Disease

Lieberman, AN; Gopinathan, G; Neophytides, A

Recent developments in Parkinson's disease 2. New York : Raven Press, c1987. p.249-256. (591002)

See All Publications (66)